Partial peptide degradation by aminopeptidases may be used to generate MHC-presented peptide antigens, or, after full hydrolysis, the generated free amino acids can be reutilized by the CLL cells for protein synthesis. Here, CPQ is linked to B-cell chronic lymphocytic leukemia.